Jane Street
YARW

Jane Street’s Yarrow Bioscience YARW Stock Holding History

Jane Street’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8
Closed -$79K – 7642
2020
Q1 		$79K Buy
+8
New +$125K ﹤0.01% 5005

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Jane Street's YARW Position: Q2 2026 in Review

Jane Street reduced its Yarrow Bioscience (YARW) stake by 57% in Q2 2026, selling an estimated $35.5K and leaving 819 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #11134.

Jane Street first reported a position in YARW in Q1 2020 and has held it in 14 quarters since. The position peaked at $206K in Q2 2025. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Jane Street held 819 shares of Yarrow Bioscience worth $26.7K as of Q2 2026.
  • Jane Street sold 1,094 Yarrow Bioscience shares in Q2 2026, an estimated $35.5K.
  • Yarrow Bioscience made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11134 holding.
  • Jane Street first reported a position in Yarrow Bioscience in Q1 2020 and has held it in 14 quarters since.
  • Jane Street's Yarrow Bioscience position peaked at $206K in Q2 2025.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.